Castle Biosciences Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Castle Biosciences Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10384
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Castle Biosciences Inc (Castle Biosciences) is a drug development company that develops and commercializes diagnostic and prognostic tests for cancers. The company offers tests for cutaneous melanoma, uveal melanoma and glioblastoma multiforme. Its DecisionDx-melanoma identifies stage I or II patients at high risk of metastasis based on biological information from genes within their tumor tissue. Castle Biosciences’ diagnostic and prognostic tests for cancer provide tumor-specific information for improved treatment decisions and patient outcomes. The company also provides clinician services. It has operations in Texas and Arizona, the US. Castle Biosciences is headquartered in Friendswood, Texas, the US.

Castle Biosciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Castle Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Castle Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Castle Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Castle Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Castle Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Castle Biosciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Castle Biosciences Raises USD5 Million in Venture Financing 10
Castle Biosciences Raises USD5.47 Million in Venture Financing 11
Castle Biosciences Raises USD11.7 Million in First Tranche of Series F Financing 12
Castle Biosciences Secures USD6 Million from Silicon Valley Bank 13
Castle Biosciences Raises USD11.8 Million in Series E Venture Financing 14
Castle Biosciences Raises US$1 Million In Venture Financing 15
Castle Biosciences Raises USD1.5 Million in Venture Financing 16
Castle Biosciences Raises US$1 Million In Venture Financing 17
Partnerships 18
Castle Biosciences Enters Into Licensing Agreement With Brigham and Women’s Hospital For Mesothelioma Test 18
Castle Biosciences Enters Into Licensing Agreement With Indiana University Research & Technology 19
Castle Biosciences Inc – Key Competitors 20
Castle Biosciences Inc – Key Employees 21
Castle Biosciences Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
May 09, 2017: Oxford Finance and Silicon Valley Bank Close $20 Million Credit Facility with Castle Biosciences 23
Corporate Communications 24
Dec 07, 2017: Castle Biosciences Announces the Appointment of Frank Stokes as Chief Financial Officer 24
May 09, 2017: Oxford Finance and Silicon Valley Bank Close $20 Million Credit Facility with Castle Biosciences 25
Legal and Regulatory 26
Jan 17, 2017: Castle Biosciences’ New Laboratory Receives Accreditation from College of American Pathologists 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Castle Biosciences Inc, Medical Equipment, Key Facts 2
Castle Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Castle Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Castle Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Castle Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Castle Biosciences Inc, Deals By Market, 2012 to YTD 2018 8
Castle Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Castle Biosciences Raises USD5 Million in Venture Financing 10
Castle Biosciences Raises USD5.47 Million in Venture Financing 11
Castle Biosciences Raises USD11.7 Million in First Tranche of Series F Financing 12
Castle Biosciences Secures USD6 Million from Silicon Valley Bank 13
Castle Biosciences Raises USD11.8 Million in Series E Venture Financing 14
Castle Biosciences Raises US$1 Million In Venture Financing 15
Castle Biosciences Raises USD1.5 Million in Venture Financing 16
Castle Biosciences Raises US$1 Million In Venture Financing 17
Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test 18
Castle Biosciences Enters Into Licensing Agreement With Indiana University Research & Technology 19
Castle Biosciences Inc, Key Competitors 20
Castle Biosciences Inc, Key Employees 21
Castle Biosciences Inc, Other Locations 22

List of Figures
Castle Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Castle Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Castle Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Castle Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Castle Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Castle Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Castle Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Castle Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Castle Biosciences Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • United Therapeutics Corp (UTHR):企業の財務・戦略的SWOT分析
    United Therapeutics Corp (UTHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Columbia Power Corp:企業の戦略的SWOT分析
    Columbia Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Neurovance Inc-製薬・医療分野:企業M&A・提携分析
    Summary Neurovance Inc (Neurovance) is a clinical stage neuroscience focused company that develops centanafadine (CTN) SR for adult and pediatric Attention Deficit Hyperactivity Disorder (ADHD). CTN, formerly EB-1020, is a novel triple reuptake inhibitor that acts as a functional hybrid with activit …
  • Berry Global Group Inc:戦略・SWOT・企業財務分析
    Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report Summary Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Groupama S.A.:企業の戦略・SWOT・財務情報
    Groupama S.A. - Strategy, SWOT and Corporate Finance Report Summary Groupama S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Evergreen Packaging Llc
    Evergreen Packaging Llc - Strategy, SWOT and Corporate Finance Report Summary Evergreen Packaging Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • University of Texas MD Anderson Cancer Center:企業の戦略的SWOT分析
    University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • PharmaCell BV-製薬・医療分野:企業M&A・提携分析
    Summary PharmaCell BV (PharmaCell) is a contract manufacturing organization that offers services for cellular therapies and regenerative medicine. The organization manufactures commercial cell therapy products in the European markets. Its services include cell culture scale-up, manufacturing of adva …
  • New York Independent System Operator Inc:企業の戦略的SWOT分析
    New York Independent System Operator Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • The Saudi Investment Bank:企業の戦略・SWOT・財務分析
    The Saudi Investment Bank - Strategy, SWOT and Corporate Finance Report Summary The Saudi Investment Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Premier Marketing Public Company Limited:戦略・SWOT・企業財務分析
    Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Oberoi Realty Limited:企業の戦略・SWOT・財務情報
    Oberoi Realty Limited - Strategy, SWOT and Corporate Finance Report Summary Oberoi Realty Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • PriceSmart, Inc.:企業の戦略・SWOT・財務分析
    PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report Summary PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • TOKIN Corp:企業の戦略的SWOT分析
    TOKIN Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • The Federal Bank Limited:企業の戦略・SWOT・財務分析
    The Federal Bank Limited - Strategy, SWOT and Corporate Finance Report Summary The Federal Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Avaya Inc.:企業の戦略・SWOT・財務情報
    Avaya Inc. - Strategy, SWOT and Corporate Finance Report Summary Avaya Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Ecopetrol S.A.:企業のM&A・事業提携・投資動向
    Ecopetrol S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ecopetrol S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Intelsat S.A. (I):企業の財務・戦略的SWOT分析
    Intelsat S.A. (I) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Brambles Limited (BXB):企業の財務・戦略的SWOT分析
    Brambles Limited (BXB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Amcor Limited
    Amcor Limited - Strategy, SWOT and Corporate Finance Report Summary Amcor Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆